Shan Wu
Corporate Officer/Principal en VIRIDIAN THERAPEUTICS, INC. .
Cargos activos de Shan Wu
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| VIRIDIAN THERAPEUTICS, INC. | Corporate Officer/Principal | 30/10/2023 | - |
Historial de carrera de Shan Wu
Antiguos cargos conocidos de Shan Wu.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| MAGENTA THERAPEUTICS | Contacto de Relaciones con Inversores | 01/10/2021 | 01/09/2023 |
| Corporate Officer/Principal | 01/10/2021 | 01/09/2023 |
Formación de Shan Wu.
| Massachusetts Institute of Technology | Doctorate Degree |
| University of Virginia | Undergraduate Degree |
Estadísticas
Internacional
| Estados Unidos | 5 |
Operativa
| Corporate Officer/Principal | 2 |
| Doctorate Degree | 1 |
| Undergraduate Degree | 1 |
Sectorial
| Health Technology | 3 |
| Finance | 2 |
| Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| VIRIDIAN THERAPEUTICS, INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Magenta Therapeutics, Inc.
 Magenta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Magenta Therapeutics, Inc. is a biotechnology company, which focuses on improving stem cell transplantation. Its platform includes MGTA-117, MGTA-145, and CD45-ADC. The company was founded by David T. Scadden, Derrick J. Rossi, Alan Tyndall, Luigi Naldini, Robert Negrin, John F. Dipersio, and Jason Gardner on June 17, 2015 and is headquartered in Cambridge, MA. | Health Technology |
- Bolsa de valores
- Insiders
- Shan Wu
- Experiencia
